A new study suggests that patients who contract COVID-19 and completely recover from all symptoms do not show evidence of lasting damage to the lungs. The multicenter observational study looked at COVID-19 survivors who experienced asymptomatic, moderate or severe COVID-19 infections and underwent an unrelated elective lung operation for lung nodules or lung cancer sometime after recovery.
Researchers in Moffitt Cancer Center’s Lung Cancer Center of Excellence believe a combination of checkpoint inhibitors with adoptive cell therapy could be the answer for non-small cell lung cancer patients. Results of their investigator-initiated phase 1 clinical trial evaluating the checkpoint inhibitor nivolumab in combination with tumor infiltrating lymphocyte (TIL) therapy was published today in Nature Medicine.
Increased air pollution in recent years has exacerbated health risks for people who suffer from pulmonary diseases and these dynamics underscore the importance of increasing the efficacy of drug delivery devices that administer active pharmaceutical ingredients to treat respiratory illnesses. In Physics of Fluids, researchers describe developing a computational evaluation of drug delivery through both pressurized metered-dose inhalers and dry powder inhalers to determine how the process can be improved.
The Red Tide Respiratory Forecast developed by the National Oceanic and Atmospheric Administration’s National Centers for Coastal Ocean Science (NOAA-NCCOS) in partnership with the Gulf of Mexico Coastal Ocean Observing System (GCOOS), the state of Florida and others, is now fully supported and available to the public.
The risk that both tobacco and electronic cigarettes can pose to regular smokers’ health has been well documented, but a new UCLA study illustrates just how quickly vaping can affect the cells of even healthy younger nonsmokers.
The ATS Research Program today announced two new grant opportunities made possible by the American Lung Association/ATS/CHEST Foundation Respiratory Health Equity Research Award. Each grant provides $100,000 in funding per year for two years.
A KAIST immunology research team found that a specific subtype of macrophages that originated from blood monocytes plays a key role in the hyper-inflammatory response in SARS-CoV-2 infected lungs, by performing single-cell RNA sequencing of bronchoalveolar lavage fluid cells.
In a proof-of-concept study, researchers at Children’s Hospital of Philadelphia (CHOP) have created a coating that can be applied to endotracheal tubes and release antimicrobial peptides that target infectious bacteria with specificity. The innovation could reduce upper-airway bacterial inflammation during intubation, a situation that can lead to chronic inflammation and a condition called subglottic stenosis, the narrowing of the airway by an accumulation of scar tissue. The findings were published recently in the journal The Laryngoscope.
Researchers have discovered a protein that may predict disease severity for scleroderma-associated interstitial lung disease, the leading cause of death for patients with the rare autoimmune condition. Higher circulating levels of the CTRP9 were associated with more severe lung disease, while low levels were associated with preserved function.
Scientists at Children’s Hospital of Philadelphia (CHOP) have identified two proteins that could be used for a potential vaccine against nontypeable Haemophilus influenzae (NTHi). Working in a mouse model, the investigators found that administering two bacterial adhesive proteins that play a key role in helping the bacteria to latch on to respiratory cells and initiate respiratory tract infection stimulated protective immunity against diverse NTHi strains, highlighting the vaccine potential.
NEWS STORIES IN THIS ISSUE: -Study: Race and Ethnicity May Impact Prevalence and Treatment of Heart Valve Dysfunction -Johns Hopkins Medicine Suggests Eliminating Nerve Cell Protein May Stop ALS, Dementia -Researchers Tell Doctors to Avoid Routine Urinary Tests for Older Patients with Delirium -Johns Hopkins Medicine Researchers Show How Air Pollution May Cause Chronic Sinusitis -Researchers ID Location on Brain Protein Linked to Parkinson’s Disease Development -COVID-19 News: The Return of Onsite Schooling — and How to Keep Your Kids Safe from COVID
Focus of the work is bolstering B-cell immunity to help body beat bacteria
The ATS Research Program and the American Lung Association have awarded Laurie Eldredge, MD, PhD, of the University of Washington/Seattle Children’s Hospital a $100,000 Partner Grant. The ATS Research Program Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
Researchers at Cornell have developed a way to analyze how individual immune cells react to the bacteria that cause tuberculosis. It could pave the way for new vaccine strategies and provide insights into fighting other infectious diseases.
Researchers at Weill Cornell Medicine and NewYork-Presbyterian in New York have discovered that injecting mice with pulmonary endothelial cells—the cells that line the walls of blood vessels in the lung—can reverse the symptoms of emphysema. The study, which will be published July 21 in the Journal of Experimental Medicine (JEM), may lead to new treatments for chronic obstructive pulmonary disease (COPD), an inflammatory lung disease associated with smoking that is thought to be the third leading cause of death worldwide.
In response to an announcement from Philip Morris International that the company has agreed to acquire Vectura, a British inhaled medicine company, American Lung Association President and CEO Harold Wimmer and American Thoracic Society President Lynn Schnapp MD, ATSF shared the following statement:
The struggle to get your child to go to sleep and stay asleep is something most parents can relate to. Once the bedtime battle is over and the kids have finally nodded off, many parents tune out as well. But University of South Australia researcher Professor Kurt Lushington is calling for parents to check on their small snoozers before switching off.
لندن – أعلنت Mayo Clinic Healthcare، وهي عيادة خارجية تقدم خدمات الرعاية الصحية الشخصية، من الفحوصات الوقائية، وخطط العافية المصممة بحسب حاجة المريض، إلى اخذ اراء الثانية للتشخيصات المعقدة، عن إضافة العديد من التخصصات الطبية، بما في ذلك: طب القلب، وطب الجهاز الهضمي، والطب الرئوي.
Resistance to antibiotics is common and often deadly among children with pneumonia in Bangladesh, according to a new study coauthored by researchers from Massachusetts General Hospital (MGH) with colleagues at the International Centre for Diarrhoeal Disease Research, Bangladesh (abbreviated as icddr,b).
Mayo Clinic Healthcare（妙佑医疗国际医疗保健）是一家提供个性化医疗保健服务的门诊诊所，服务范围涵盖预防性筛查、保健计划定制以及疑难诊断第二诊疗意见。该诊所目前正进行增设如下医学专科：心脏病学、胃肠病学和肺病医学。
A Mayo Clinic Healthcare, uma clínica ambulatorial que oferece cuidados de saúde desde exames preventivos e planos de bem-estar personalizados até segundas opiniões sobre diagnósticos complexos, passa a oferecer também especialidades como cardiologia, gastroenterologia e pneumologia.
Mayo Clinic Healthcare es una clínica de consulta externa que ofrece atención médica personalizada con detecciones preventivas, planes individualizados de bienestar y segundas opiniones para diagnósticos complejos que ahora añade varias especialidades médicas, entre ellas, cardiología, gastroenterología y neumología.
Findings from an international multicenter trials showed that while a full dose of heparin didn't statistically significantly lower incidence of the primary composite of death, mechanical ventilation or ICU admission compared with low-dose heparin, therapeutic heparin did reduce the odds of all-cause death by 78 percent.
Scientists find that short chain fatty acids can be used to reduce susceptibility to SARS-CoV-2 infection and mortality from COVID-19
The ATS Research Program is pleased to announce that William Zhang, MD, of Weill Cornell Medical Center is the recipient of the 2020-2021 ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome. The $50,000 award will support Dr. Zhang’s research study, “Hyperferritinemia in COVID-19 ARDS: Friend or Foe?”
Mayo Clinic Healthcare, an outpatient clinic that provides personalized health care ranging from preventive screenings and tailored wellness plans to second opinions for complex diagnoses, is adding several medical specialties including cardiology, gastroenterology and pulmonary medicine.
The ATS Research Program and the chILD Foundation have awarded Anthony Shum, MD, of the University of California, San Francisco $80,000. The award will support Dr. Shum’s research project, “Defining the pathogenesis of childhood ILD in COPA syndrome.”
Today, the ATS Research Program announced that Jessica Blackburn, PhD, of Vanderbilt University has been awarded the ATS/GSK Research Grant in Obstructive Lung Disease. The grant was funded through GlaxoSmithKline (GSK) support of the ATS Research Program.
A decade’s worth of data shows that neonatologists are shifting the type of respiratory support they utilize for preterm infants, a move that could lead to improved health outcomes.
The lung transplant team at UC San Diego Health performed San Diego County’s first transplant surgery with lungs donated after cardiac death, an approach that could mean more opportunities to save the lives of those in critical need of new lungs.
Working out just five minutes daily via a practice described as "strength training for your breathing muscles" lowers blood pressure and improves some measures of vascular health as well as, or even more than, aerobic exercise or medication, new CU Boulder research shows.
A new study finds that exposure to e-cigarette vapor leads to higher levels of the coronavirus receptor ACE-2 in lungs of mice, with nicotine enhancing that increase in male mice.
The compound TA-C is metabolized by TB bacteria – weakening the germ from within like a ‘Trojan horse’ attack
Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19.
Aerosol generated by playing woodwind and brass instruments is less than that produced when vocalising (speaking and singing) and is no different than a person breathing, new research has found.
Researchers at Children’s Hospital of Philadelphia (CHOP) have discovered that a specific type of lung cell exhibits unconventional immune properties and may contribute to the outcome of respiratory viral infections. The researchers focused on type II alveolar (AT2) cells, which are non-immune cells of the lung that are critical for basic lung health and tissue repair after lung injury. They found that AT2 cells express high levels of major histocompatibility complex II (MHC-II), an important immune system trigger, and that AT2 MHC-II expression appears to confer an appreciable advantage in the outcome of respiratory viral infection. The findings were published today in Nature Communications.
A new study confirms the low likelihood that coronavirus contamination on hospital surfaces is infectious. The study is the original report on recovering near-complete SARS-CoV-2 genome sequences directly from surface swabs.
Israeli scientists have demonstrated a novel means of diagnosing tuberculosis by means of a sticker patch that catches compounds released by the skin. Using an artificial intelligence (AI) analysis of these compounds, the scientists were able to provide a quick, non-invasive diagnosis.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right